The FDA’s next move, $549 headphones and overly optimistic?

The FDA’s next move, $549 headphones and overly optimistic?

  • Autor
  • Osa
      245
  • Avaldatud
      8. dets 2020
  • Kirjastaja
0 Hinnangud
0
Osa
245 of 1598
Kestus
45 min
Keel
inglise
Vorming
Kategooria
Majandus ja ettevõtlus

Pfizer’s COVID-19 vaccinations are underway in the UK, while the FDA is expected to give U.S. approval this week. We’ll break down this monumental rollout.

Plus, Apple says its new fitness subscription service will launch next week, and unveils the new $549 Airpods Max. We’ll discuss Apple’s ‘flex’ in Rapid Fire.

And, Goldman Sachs raises its GDP outlook, as JPMorgan says any market correction is a buying opportunity. Is the market getting overly optimistic? We’ll debate.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Device Banner Block-copy 894x1036
Cover for The FDA’s next move, $549 headphones and overly optimistic?

Muud podcastid, mis võivad sulle meeldida ...